Clinical trial
Efficacy and Mechanism of Yangyin Roujin Formula in Fibromyalgia Syndrome: A Randomized Controlled Trial
NCT07736144 is registered in ClinicalTrials.gov with Juan Jiao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Mechanism of Yangyin Roujin Formula in Fibromyalgia Syndrome: A Randomized Controlled Trial
- Lead sponsor
- Juan Jiao
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 1, 2025
- Completion date
- December 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fibromyalgia syndrome